NLG802 is a proagent of indoximod, an orally active indoleamine 2,3-dioxygenase (IDO) inhibitor.
References
[1] Kumar S, et al. Discovery of indoximod prodrugs and characterization of clinical candidate NLG802. Eur J Med Chem. 2020 Jul 15;198:112373. DOI:10.1016/j.ejmech.2020.112373